News & Events

Fundraising On The Run: 7 Marathons in 7 Days on 7 Continents

Fundraising really doesn’t have to be this hard. Bryan Metoyer has just finished the World Marathon Challenge—an incredible achievement made even more meaningful by his goal in taking it on,…

US FDA Accepts Investigational New Drug Application for Coya Therapeutics’ Experimental Therapy for FTD

Biotechnology company Coya Therapeutics announced that the United States Food and Drug Administration had accepted its investigational new drug (IND) application for its COYA 302 experimental therapy for FTD. The…

Recognizing the Easily Mistaken Signs of Young-Onset Dementia

Signs of young-onset dementias such as FTD are difficult to diagnose, according to an article on The Telegraph website (paywall; one week free access with registration), because few think of…

Advancing Hope: FTD Staff attend the Amyotrophic Lateral Sclerosis Motor Neuron Disease Annual Symposium

Shana Dodge, PhD, AFTD’s Director of Research Engagement, and Kim Jenny, MS, LCGC, AFTD’s Manager of Genetic Initiatives, attended the Amyotrophic Lateral Sclerosis Motor Neuron Disease Annual Symposium, held in…

Dear HelpLine: Compulsive Sexual Behavior

Dear HelpLine, My spouse with bvFTD has some behaviors that are difficult to talk about. He is obsessed with pornography, which is very different than who he used to be.…

Prevail Therapeutics Discontinues PR006 Trial

On February 4, Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly & Co., announced the discontinuation of the PR006 “PROCLAIM” drug development program for FTD with GRN variants due…

GUIDE: A New Medicare Pilot Program Can Help Families Facing FTD

Professionals who work in the community know that dementia support services can be fragmented and difficult for families to navigate. Needed services are often provided by a variety of different…

FTD Call To Action Featured In Canadian Media

In an opinion piece published recently in the Edmonton (Alberta, CA) Journal, Naomi Mison called for reform of the bureaucracy and improvement of dementia care access in Canada. She should know: Her…